Jeff Cislini - Mar 23, 2023 Form 3 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: General Counsel
Signature: /s/ Jack Anders, as Attorney-in-fact for Jeff Cislini
Stock symbol: RVMD
Transactions as of: Mar 23, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/29/2023, 04:11 PM
Next filing: Jun 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RVMD	Common Stock						45.6K	Mar 23, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RVMD	Stock Option (Right to Buy)							Mar 23, 2023	Common Stock	42K	$36.57	Direct	F2
holding	RVMD	Stock Option (Right to Buy)							Mar 23, 2023	Common Stock	13.4K	$42.45	Direct	F3
holding	RVMD	Stock Option (Right to Buy)							Mar 23, 2023	Common Stock	29.7K	$18.56	Direct	F4
holding	RVMD	Stock Option (Right to Buy)							Mar 23, 2023	Common Stock	30.1K	$21.61	Direct	F5
holding	RVMD	Stock Option (Right to Buy)							Mar 23, 2023	Common Stock	77.7K	$26.50	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 41,748 restricted stock units.
F2	Twenty-five percent of the total shares subject to the option vest on the first anniversary measured from June 15, 2020 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F3	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 4, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F4	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F5	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F6	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.